Trials / Recruiting
RecruitingNCT07239219
The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
To Determine the Efficacy of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Given the high burden of post-catheter removal UTIs, this study aims to evaluate Irrisept instillation as a non-antibiotic intervention to reduce infection rates. By comparing Irrisept to saline irrigation, the study will provide critical insights into the efficacy of antiseptic bladder irrigation in preventing UTIs while minimizing antibiotic use. If successful, this approach could lead to new clinical guidelines for catheter removal protocols, improving patient outcomes and reducing healthcare costs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 0.05% Chlorhexidine Gluconate | 0.05% CHG is instilled into the bladder prior to trial of void. |
| OTHER | Normal Saline | Bladder is back filled with normal saline. |
Timeline
- Start date
- 2025-12-31
- Primary completion
- 2028-01-01
- Completion
- 2028-01-01
- First posted
- 2025-11-20
- Last updated
- 2025-11-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07239219. Inclusion in this directory is not an endorsement.